Regulation of PXR in drug metabolism: chemical and structural perspectives

被引:2
作者
Gee, Rebecca R. Florke [1 ,2 ]
Huber, Andrew D. [2 ,3 ]
Chen, Taosheng [2 ,3 ]
机构
[1] St Jude Childrens Res Hosp, Grad Sch Biomed Sci, Memphis, TN USA
[2] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN USA
[3] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 262 Danny Thomas Pl,Mail Stop 1000, Memphis, TN 38105 USA
关键词
Detoxification; drug-drug interactions; drug metabolism; nuclear receptor; posttranslational modifications; pregnane X receptor; PREGNANE-X-RECEPTOR; NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; UGT1A1; GENE-EXPRESSION; PRIMARY CULTURED RAT; ST JOHNS WORT; NUCLEAR RECEPTORS; XENOBIOTIC RECEPTOR; ACTIVATED RECEPTOR; CROSS-TALK;
D O I
10.1080/17425255.2024.2309212
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
IntroductionPregnane X receptor (PXR) is a master xenobiotic sensor that transcriptionally controls drug metabolism and disposition pathways. PXR activation by pharmaceutical drugs, natural products, environmental toxins, etc. may decrease drug efficacy and increase drug-drug interactions and drug toxicity, indicating a therapeutic value for PXR antagonists. However, PXR's functions in physiological events, such as intestinal inflammation, indicate that PXR activators may be useful in certain disease contexts.Areas coveredWe review the reported roles of PXR in various physiological and pathological processes including drug metabolism, cancer, inflammation, energy metabolism, and endobiotic homeostasis. We then highlight specific cellular and chemical routes that modulate PXR activity and discuss the functional consequences. Databases searched and inclusive dates: PubMed, 1 January 1980 to 10 January 2024Expert opinionKnowledge of PXR's drug metabolism function has helped drug developers produce small molecules without PXR-mediated metabolic liabilities, and further understanding of PXR's cellular functions may offer drug development opportunities in multiple disease settings.
引用
收藏
页码:9 / 23
页数:15
相关论文
共 50 条
  • [1] Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond
    Chai, Xiaojuan
    Zeng, Su
    Xie, Wen
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (03) : 253 - 266
  • [2] PXR variants: the impact on drug metabolism and therapeutic responses
    Brewer, C. Trent
    Chen, Taosheng
    ACTA PHARMACEUTICA SINICA B, 2016, 6 (05) : 441 - 449
  • [3] PXR as the tipping point between innate immune response, microbial infections, and drug metabolism
    Daniel Bautista-Olivier, Carlos
    Elizondo, Guillermo
    BIOCHEMICAL PHARMACOLOGY, 2022, 202
  • [4] PXR antagonists and implication in drug metabolism
    Mani, Sridhar
    Dou, Wei
    Redinbo, Matthew R.
    DRUG METABOLISM REVIEWS, 2013, 45 (01) : 60 - 72
  • [5] Regulation of hepatic drug metabolism: Role of the nuclear receptors PXR and CAR
    Liddle, C
    Goodwin, B
    SEMINARS IN LIVER DISEASE, 2002, 22 (02) : 115 - 122
  • [6] Regulation of hepatic energy metabolism by the nuclear receptor PXR
    Hakkola, Jukka
    Rysa, Jaana
    Hukkanen, Janne
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2016, 1859 (09): : 1072 - 1082
  • [7] Regulation of PXR Function by Coactivator and Corepressor Proteins: Ligand Binding Is Just the Beginning
    Rigalli, Juan Pablo
    Theile, Dirk
    Nilles, Julie
    Weiss, Johanna
    CELLS, 2021, 10 (11)
  • [8] A current structural perspective on PXR and CAR in drug metabolism
    Buchman, Cameron D.
    Chai, Sergio C.
    Chen, Taosheng
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (06) : 635 - 647
  • [9] Insights into the critical role of the PXR in preventing carcinogenesis and chemotherapeutic drug resistance
    Niu, Xiaxia
    Wu, Ting
    Li, Gege
    Gu, Xinsheng
    Tian, Yanan
    Cui, Hongmei
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (02): : 742 - 759
  • [10] Regulation of Nuclear Receptors PXR and CAR by Small Molecules and Signal Crosstalk: Roles in Drug Metabolism and Beyond
    Poudel, Shyaron
    Huber, Andrew D.
    Chen, Taosheng
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (02) : 228 - 236